Literature DB >> 26407578

Relevance of GSTM1, GSTT1 and GSTP1 Gene Polymorphism to Breast Cancer Susceptibility in Mizoram Population, Northeast India.

Lalro Kimi1, Souvik Ghatak1, Ravi Prakash Yadav1, Lalhma Chhuani2, Doris Lallawmzuali3, Jeremy L Pautu3, Nachimuthu Senthil Kumar4.   

Abstract

The enzymes encoded by glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) genes are involved in the metabolism of wide range of carcinogens that are ubiquitous in the environment. Homozygous deletions of the GSTM1 and GSTT1 genes are commonly found and result in lack of enzyme activity. This study was undertaken to evaluate the association between GSTM1, GSTT1 and GSTP1 gene polymorphism and breast cancer risk in Mizoram population. Odd ratio (OR) and 95% confidence interval (CI) from conditional logistic regression model were used to estimate the association between genetic polymorphism and breast cancer risk. The GSTM1 and GSTT1 null genotypes were associated with an increased risk of breast cancer [OR = 10.80 (95% CI 1.16-100.43)]. The risk of breast cancer associated with the GSTT1 null genotype was observed to be low among postmenopausal women. When considered together, GSTM1 and GSTT1 genotypes were found to be associated with an increased risk of breast cancer. The relationship between GSTM1 and GSTT1 gene deletions and breast cancer risk was substantially altered by consumption of Smoked Meat/Vegetable. In the present study, GSTP1Ile105Val (rs1695) polymorphism was related to breast cancer susceptibility or phenotype. Our data provides evidence for substantially increased risk of breast cancer associated with GSTM1 and/or GSTT1 homozygous gene deletions in Mizoram population.

Entities:  

Keywords:  Breast cancer; Carcinogen; Glutathione S-transferases; Mizo-Mongoloid; Polymorphism; Xenobiotics

Mesh:

Substances:

Year:  2015        PMID: 26407578     DOI: 10.1007/s10528-015-9698-5

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  7 in total

1.  Glutathione S-Transferase P1 313 (A > G) Ile105Val Polymorphism Contributes to Cancer Susceptibility in Indian Population: A Meta-analysis of 39 Case-Control Studies.

Authors:  Raju K Mandal; Rama D Mittal
Journal:  Indian J Clin Biochem       Date:  2018-09-17

2.  Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.

Authors:  Tajamul Hussain; Salman Alrokayan; Upadhyay Upasna; Manickam Pavithrakumari; Jaganathan Jayapriya; Vijay Kumar Kutala; Shaik Mohammad Naushad
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

3.  GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma.

Authors:  Thanet Sophonnithiprasert; Pensri Saelee; Tanett Pongtheerat
Journal:  J Gastrointest Oncol       Date:  2019-04

4.  Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.

Authors:  Magdy M Youssef; Afaf M Elsaid; Rasha A El-Saeed; Riyadh T Mukhlif; Hisham Megahed; Adel I Al-Alawy; Rami M Elshazli
Journal:  Biochem Genet       Date:  2021-05-03       Impact factor: 1.890

5.  Combined effects of GSTM1 and GSTT1 polymorphisms on breast cancer risk: A MOOSE-compliant meta-analysis and false-positive report probabilities test.

Authors:  Li-Feng Miao; Xiao-Yan Wang; Xiang-Hua Ye; Meng-Shen Cui; Xiao-Feng He
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  Role of Glutathione S-Transferase M1 and Glutathione S Transferase Theta 1 Gene Polymorphism, Histopathological, and Immunohistochemistry in Carcinoma Breast.

Authors:  Vijay Kumar Bodal; Medhavi Dhir; Kuldip Singh Ahi; Sarbhjit Kaur; Malkiat Singh; Lachhima Bandhari
Journal:  Int J Appl Basic Med Res       Date:  2021-11-17

7.  Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility.

Authors:  Amir Farmohammadi; Vahid Arab-Yarmohammadi; Ramin Ramzanpour
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.